The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Enhanced premium subsidies were first made available under the American Rescue Plan Act and extended until the end of 2025 under the Inflation Reduction Act. This analysis shows the impact that enhanced subsidies have had on enrollment and premium payments, and the potential implications if the enhanced subsidies expire.
This data note analyzes health care expenditures for immigrants and U.S.-born people using data from the Medical Expenditures Panel Survey.
Firearm deaths increased sharply over the past decade, rising from 92 deaths per day to 132 deaths per day from 2012 to 2022. Firearms are the leading cause of total suicides and homicides, making up 55% of all suicide deaths and 79% of all homicides in 2022.
This literature review identifies studies examining the impact of the Mexico City Policy, from 2001 to the present, with particular focus on capturing recent studies assessing the policy under the Trump administration.
Medicaid paid for more than half of the $415 billion that the US spent on long-term services and supports in 2022, most of which went to home and community-based services as well as to care in nursing homes and other institutional settings.
Includes all of PEPFAR’s multi-year strategies, as well as related documents.
Includes PEPFAR’s original authorizing legislation, as well as each subsequent reauthorization legislation.
The COP/ROP guidance underpins the development of annual plans by both bilateral and regional PEPFAR programs.
This brief analyzes 2024 Medicare Part D enrollment, premiums, and cost sharing. The analysis highlights the continued growth in Medicare Advantage enrollment in the Part D marketplace and substantially higher average monthly premiums for stand-alone Part D drug plan coverage. Changes to the Part D benefit included in the Inflation Reduction Act are helping to lower out-of-pocket costs for patients but could also contribute to higher-priced Part D coverage.
This analysis examines the extent to which states are providing health benefits to their Medicare-eligible retirees through Medicare Advantage arrangements. In 2024, a majority of states offer Medicare Advantage plans to their state retirees, with 13 offering Medicare Advantage exclusively.
© 2025 KFF